Ad is loading...
NNVC
Price
$1.34
Change
+$0.06 (+4.69%)
Updated
Nov 22 closing price
4 days until earnings call
ORMP
Price
$2.34
Change
+$0.03 (+1.30%)
Updated
Nov 22 closing price
95 days until earnings call
Ad is loading...

NNVC vs ORMP

Header iconNNVC vs ORMP Comparison
Open Charts NNVC vs ORMPBanner chart's image
NanoViricides
Price$1.34
Change+$0.06 (+4.69%)
Volume$133.74K
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.34
Change+$0.03 (+1.30%)
Volume$106.95K
CapitalizationN/A
NNVC vs ORMP Comparison Chart
Loading...
NNVC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NNVC vs. ORMP commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NNVC is a Hold and ORMP is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (NNVC: $1.34 vs. ORMP: $2.34)
Brand notoriety: NNVC and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NNVC: 83% vs. ORMP: 113%
Market capitalization -- NNVC: $19.22M vs. ORMP: $94.33M
NNVC [@Biotechnology] is valued at $19.22M. ORMP’s [@Biotechnology] market capitalization is $94.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NNVC’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • NNVC’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, NNVC is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NNVC’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • NNVC’s TA Score: 4 bullish, 5 bearish.
  • ORMP’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NNVC is a better buy in the short-term than ORMP.

Price Growth

NNVC (@Biotechnology) experienced а +8.94% price change this week, while ORMP (@Biotechnology) price change was +4.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

NNVC is expected to report earnings on Feb 12, 2025.

ORMP is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($94.3M) has a higher market cap than NNVC($19.2M). NNVC YTD gains are higher at: 31.373 vs. ORMP (1.299). ORMP has higher annual earnings (EBITDA): 9.44M vs. NNVC (-8.67M). ORMP has more cash in the bank: 142M vs. NNVC (3.87M). ORMP has less debt than NNVC: ORMP (429K) vs NNVC (1.5M). NNVC (0) and ORMP (0) have equivalent revenues.
NNVCORMPNNVC / ORMP
Capitalization19.2M94.3M20%
EBITDA-8.67M9.44M-92%
Gain YTD31.3731.2992,416%
P/E RatioN/A21.27-
Revenue00-
Total Cash3.87M142M3%
Total Debt1.5M429K350%
FUNDAMENTALS RATINGS
NNVC vs ORMP: Fundamental Ratings
NNVC
ORMP
OUTLOOK RATING
1..100
7068
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9884
PRICE GROWTH RATING
1..100
6558
P/E GROWTH RATING
1..100
10060
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NNVC's Valuation (28) in the Biotechnology industry is somewhat better than the same rating for ORMP (67) in the Pharmaceuticals Other industry. This means that NNVC’s stock grew somewhat faster than ORMP’s over the last 12 months.

NNVC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that NNVC’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as NNVC (98) in the Biotechnology industry. This means that ORMP’s stock grew similarly to NNVC’s over the last 12 months.

ORMP's Price Growth Rating (58) in the Pharmaceuticals Other industry is in the same range as NNVC (65) in the Biotechnology industry. This means that ORMP’s stock grew similarly to NNVC’s over the last 12 months.

ORMP's P/E Growth Rating (60) in the Pharmaceuticals Other industry is somewhat better than the same rating for NNVC (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than NNVC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NNVCORMP
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
NNVC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BSBR4.530.16
+3.66%
Banco Santander (Brasil) SA
OBK35.020.77
+2.25%
Origin Bancorp
IRTC73.990.09
+0.12%
iRhythm Technologies
AMS3.14-0.02
-0.63%
American Shared Hospital Services
GNFT4.20-0.04
-0.94%
Genfit SA

NNVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNVC has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NNVC jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
+4.69%
MDGL - NNVC
34%
Loosely correlated
+5.53%
CYTK - NNVC
31%
Poorly correlated
+3.00%
IFRX - NNVC
30%
Poorly correlated
+0.97%
AXON - NNVC
29%
Poorly correlated
+0.90%
ORMP - NNVC
28%
Poorly correlated
+1.30%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BPMC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+1.30%
BPMC - ORMP
44%
Loosely correlated
-2.56%
BTAI - ORMP
44%
Loosely correlated
-10.80%
INO - ORMP
44%
Loosely correlated
+0.25%
MBIO - ORMP
44%
Loosely correlated
-1.35%
VERV - ORMP
44%
Loosely correlated
+5.43%
More